Hiroichi Kobayashi Selected Research

Fluorouracil (Carac)

1/2005

Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroichi Kobayashi Research Topics

Disease

6	Squamous Cell Carcinoma of Head and Neck 06/2013 - 05/2003
3	Neoplasms (Cancer) 02/2014 - 07/2003
2	Margins of Excision 02/2014 - 10/2008
2	Carcinoma (Carcinomatosis) 12/2008 - 07/2003
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 02/2014
1	Cicatrix (Scar) 12/2008
1	Neoplasm Metastasis (Metastasis) 07/2006
1	Tongue Neoplasms (Tongue Neoplasm) 01/2004
1	Lymphatic Metastasis 01/2004
1	Verrucous Carcinoma 07/2003
1	Neutropenia 05/2003

Drug/Important Bio-Agent (IBA)

2	Indigo Carmine (Indigo Blue)IBA 12/2008 - 10/2008
2	Congo RedIBA 12/2008 - 10/2008
2	moesinIBA 01/2004 - 07/2003
1	Proteins (Proteins, Gene)FDA Link 06/2013
1	Coloring Agents (Dyes)IBA 12/2008
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2005
1	Fluorouracil (Carac)FDA LinkGeneric 01/2005
1	Monoclonal AntibodiesIBA 01/2004
1	ParaffinIBA 01/2004
1	nedaplatinIBA 05/2003
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2003

Therapy/Procedure

3	Neoadjuvant Therapy 12/2008 - 05/2003
2	Adjuvant Chemotherapy 02/2014 - 07/2006
2	Drug Therapy (Chemotherapy) 02/2014 - 07/2006
2	Therapeutics 01/2004 - 05/2003
1	Radiotherapy 02/2014
1	Combination Drug Therapy (Combination Chemotherapy) 05/2003